Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Monomethyl Fumarate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,929Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    European Commission grants marketing authorisation for Vumerity
    European Commission grants marketing authorisation for Vumerity

    17 Nov 2021

    // Anna Begley EUROPEANPHARMACEUTICALREVIEW

    https://www.europeanpharmaceuticalreview.com/news/165570/european-commission-grants-marketing-authorisation-for-vumerity/

    Anna Begley EUROPEANPHARMACEUTICALREVIEW
    17 Nov 2021
    Share Share
    Banner Life Sciences Announces BAFIERTAM, a Novel Oral Fumarate Treatment
    Banner Life Sciences Announces BAFIERTAM, a Novel Oral Fumarate Treatment

    03 Sep 2020

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/banner-life-sciences-announces-bafiertam-a-novel-oral-fumarate-treatment-1600067525.pdf

    PRESS RELEASE
    03 Sep 2020
    Share Share
    Banner Life Sciences Announces Commercial Launch of BAFIERTAM
    Banner Life Sciences Announces Commercial Launch of BAFIERTAM

    16 Jul 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200716006004/en

    BUSINESSWIRE
    16 Jul 2020
    Share Share
    Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for MS
    Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for MS

    01 May 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200430005256/en/Banner-Life-Sciences-Announces-Final-FDA-Approval

    BUSINESSWIRE
    01 May 2020
    Share Share
    Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for MS
    Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for MS

    30 Apr 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200430005256/en

    BUSINESSWIRE
    30 Apr 2020
    Share Share
    Alkermes and Biogen announce new MS drug application for FDA
    Alkermes and Biogen announce new MS drug application for FDA

    18 Dec 2018

    // Anna Smith PHARMA TIMES

    http://www.pharmatimes.com/news/alkermes_and_biogen_announce_new_ms_drug_application_for_fda_1272962

    Anna Smith PHARMA TIMES
    18 Dec 2018
    Share Share